Coverage
-
November 20, 2015
Mylan and fellow generic-drug maker Perrigo told a New York federal court Friday they had settled a suit in which Mylan was accused of misleading Perrigo investors in a failed $27 billion hostile takeover attempt, after too few investors agreed to tender their shares last week.
3 other articles on this case.
View all »